Zhengye Biotechnology Holdings Inc. (ZYBT)

Overview

Zhengye Biotechnology Holding Limited is a prominent player in the field of veterinary healthcare, primarily focusing on the research, development, manufacture, and sale of veterinary vaccines tailored for livestock in China. Established in 2004, the company is headquartered in Jilin, China, and has built a reputation for delivering high-quality veterinary solutions. Additionally, Zhengye Biotechnology exports its diverse range of veterinary vaccines to international markets, including Vietnam, Pakistan, and Egypt. As a subsidiary of Securingium Holding Limited, the company benefits from greater corporate resources and strategic direction, reinforcing its position within the biotechnology sector.

Products and Services

• Swine Vaccines:

  Zhengye Biotechnology develops specialized vaccines for the swine industry, addressing common diseases that affect pigs and contributing to improved herd health and productivity.

• Cattle Vaccines:

  The company offers a comprehensive range of vaccines for cattle, protecting against various infectious diseases that can compromise livestock health and increase mortality rates.

• Goat Vaccines:

  Vaccines tailored for goats aim to prevent diseases specific to the species, enhancing their overall health, productivity, and longevity.

• Sheep Vaccines:

  Zhengye provides vaccines for sheep that bolster resistance against infectious conditions, ensuring the welfare of the flock and supporting the agricultural economy.

• Poultry Vaccines:

  The poultry vaccines offered are designed to protect chickens and other birds from viral and bacterial infections, ensuring optimal production and food safety.

• Dog Vaccines:

  In addition to livestock vaccines, Zhengye develops and sells vaccines for dogs, aimed at preventing infectious diseases and safeguarding canine health.